RHD-specific microRNA for regulation of the DEL blood group: integration of computational and experimental approaches

References

• Luettringhaus TA, Cho D, Ryang DW, et al. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors. Transfusion. 2006;46:2128–2137.10.1111/trf.2006.46.issue-12
   PubMed Web of Science ®Google Scholar
• Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet. 2001;15:10.10.1186/1471-2156-2-10
   Web of Science ®Google Scholar
• Orzińska A, Guz K, Polin H, et al. RHD variants in polish blood donors routinely typed as D–. Transfusion. 2013;53:2945–2953.
   PubMed Web of Science ®Google Scholar
• Daniels G. Variants of RhD – current testing and clinical consequences. Br J Haematol. 2013;161:461–470.10.1111/bjh.12275
   PubMed Web of Science ®Google Scholar
• Yasuda H, Ohto H, Sakuma S, et al. Secondary anti-D immunization by Del red blood cells. Transfusion. 2005;45:1581–1584.10.1111/trf.2005.45.issue-10
   PubMed Web of Science ®Google Scholar
• Kim KH, Kim KE, Woo KS, et al. Primary anti-D immunization by DEL red blood cells. Korean J Lab Med. 2009;29:361–365.10.3343/kjlm.2009.29.4.361
   PubMed Web of Science ®Google Scholar
• Gardener GJ, Legler TJ, Hyett JA, et al. Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype. Transfusion. 2012;52:2016–2019.10.1111/trf.2012.52.issue-9
   PubMed Web of Science ®Google Scholar
• Shao CP, Wang BY, Ye SH, et al. DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness. J Zhejiang Univ Sci B. 2012;13:913–918.10.1631/jzus.B1100348
   PubMed Web of Science ®Google Scholar
• Chen JC, Lin TM, Chen YL, et al. RHD 1227A is an important genetic marker for RhD el individuals. Am J Clin Pathol. 2004;122:193–198.10.1309/3XMF2NV5707TJE7X
   PubMed Web of Science ®Google Scholar
• Gorick B, McDougall DC, Ouwehand WH, et al. Quantitation of D sites on selected ‘weak D’ and ‘partial D’ red cells. Vox Sang. 1993;65:136–140.10.1111/vox.1993.65.issue-2
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Mohanty D, Gupte S, et al. Flow cytometric quantification of antigen D sites on red blood cells of partial D and weak D variants in India. Transfus Med. 2006;16:285–289.10.1111/tme.2006.16.issue-4
   PubMed Web of Science ®Google Scholar
• Kormoczi GF, Gassner C, Shao CP, et al. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion. 2005;45:1561–1567.10.1111/trf.2005.45.issue-10
   PubMed Web of Science ®Google Scholar
• Gassner C, Doescher A, Drnovsek TD, et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion. 2005;45:527–538.10.1111/trf.2005.45.issue-4
   PubMed Web of Science ®Google Scholar
• Flegel WA, von Zabern I, Wagner FF. Six years’ experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfusion. 2009;49:465–471.10.1111/trf.2009.49.issue-3
   PubMed Web of Science ®Google Scholar
• Wagner FF. RHD PCR of D-negative blood donors. Transfus Med Hemother. 2013;40:172–181.10.1159/000351604
   PubMed Web of Science ®Google Scholar
• Wang YH, Chen JC, Lin KT, et al. Detection of RhDel in RhD-negative persons in clinical laboratory. J Lab Clin Med. 2005;146:321–325.10.1016/j.lab.2005.07.007
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wang D, Wang F, et al. A comprehensive analysis of GATA-1-regulated miRNAs reveals miR-23a to be a positive modulator of erythropoiesis. Nucleic Acids Res. 2013;41:4129–4143.10.1093/nar/gkt093
   PubMed Web of Science ®Google Scholar
• Listowski MA, Heger E, Boguslawska DM, et al. microRNAs: fine tuning of erythropoiesis. Cell Mol Biol Lett. 2013;18:34–46.
   PubMed Web of Science ®Google Scholar
• Roy P, Bhattacharya G, Lahiri A, et al. hsa-miR-503 is downregulated in beta thalassemia major. Acta Haematol. 2012;128:187–189.10.1159/000339492
   PubMed Web of Science ®Google Scholar
• Chen SY, Wang Y, Telen MJ, et al. The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS One. 2008;3:e2360.10.1371/journal.pone.0002360
   PubMed Web of Science ®Google Scholar
• Sun BL, Liu X, Gao Y, et al. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients. Br J Biomed Sci. 2016;73(4):152–157.10.1080/09674845.2016.1220706
   PubMed Web of Science ®Google Scholar
• Ren X, Shen Y, Zheng S, et al. miR-21 predicts poor prognosis in patients with osteosarcoma. Br J Biomed Sci. 2016;73(4):158–162.10.1080/09674845.2016.1220710
   PubMed Web of Science ®Google Scholar
• Yadegari ZS, Akrami H, Hosseini SV, et al. miR – 146a gene polymorphism and susceptibility to gastric cancer. Br J Biomed Sci. 2016;73(4):201–203.10.1080/09674845.2016.1233790
   PubMed Web of Science ®Google Scholar
• Huang HY, Chien CH, Jen KH, et al. RegRNA: an integrated web server for identifying regulatory RNA motifs and elements. Nucleic Acids Res. 2006;34:W429–W434.10.1093/nar/gkl333
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are MicroRNA targets. Cell. 2005;120:15–20.10.1016/j.cell.2004.12.035
   PubMed Web of Science ®Google Scholar
• Enright AJ, John B, Gaul U, et al. MicroRNA targets in Drosophila. Genome Biol. 2003;5(1):R1.10.1186/gb-2003-5-1-r1
   PubMed Web of Science ®Google Scholar
• Augustin R, Endres K, Reinhardt S, et al. Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10. BMC Med Genet. 2012;13:35.10.1186/1471-2350-13-35
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3:1101–1108.10.1038/nprot.2008.73
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25:402–408.10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Du L, Schageman JJ, Subauste MC, et al. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res. 2009;7:1234–1243.10.1158/1541-7786.MCR-08-0507
   PubMed Web of Science ®Google Scholar
• Deng ZQ, Yin JY, Tang Q, et al. Over-expression of miR-98 in FFPE tissues might serve as a valuable source for biomarker discovery in breast cancer patients. Int J Clin Exp Pathol. 2014;7:1166–1171.
   PubMed Web of Science ®Google Scholar
• Nuchnoi P, Thongbus J, Srisarin A, et al. Clinical and laboratory update on the DEL variant. Lab Med. 2014;45:285–290.10.1309/LMTUZ00O7VFTGCEB
   PubMed Web of Science ®Google Scholar
• Nation BR. MicroRNAs: the future of genomic science? Br J Biomed Sci. 2016;73(4):151.
   PubMed Web of Science ®Google Scholar